Medication-related harm has a significant impact on global healthcare costs and patient outcomes. Generative artificial intelligence (GenAI) and large language models (LLM) have emerged as a promising tool in mitigating risks of medication-related harm….
Continue Reading
Background: Numerous mobile apps have been developed for patients with cancer. However, there is still no comprehensive app for patients with breast cancer that integrates evidence-based medical information, psychological support, and schedule management through…
Continue Reading
Image by freepik
What You Should Know:
– New research published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association, reveals that patients receiving continuous glucose monitors (CGM) through durable medical equipment (DME) providers…
Continue Reading
The NHS is limiting the effectiveness of AI by focusing on how the technology can improve individuals’ health, according to Dr Jessica Morley, postdoctoral researcher at Yale University’s Digital Ethics Center.
During her ‘Spotlight on…
Study Reveals Alarming Reporting Delays
A groundbreaking study published in The BMJ has uncovered a disturbing trend in the medical device industry: nearly one-third of adverse event reports are submitted late to the FDA. More…
Hospitals are poised to spend billions on AI in the coming years, but many remain ill-prepared to gauge the true return they are getting from these investments.
Health system leaders say they are still figuring…
Continue Reading
Surgical planning can be highly complicated and personalized, where a surgeon needs to balance multiple decisional dimensions including surgical effectiveness, risk, cost, and patient’s conditions and preferences. Turning to artificial intelligence is a great…
Continue Reading
What You Should Know:
– Canvas Medical, the EMR company accelerating everyday medicine, today announced the launch of Hyperscribe, an open source artificial intelligent (AI) copilot that uses ambient audio to write clinical documentation and…
Continue Reading
Demonstrating cardiovascular (CV) benefits with lipid-lowering therapy (LLT) requires long-term randomized clinical trials (RCTs) with thousands of patients. Innovative approaches such as in silico trials applying a disease computational model to virtual patients receiving…
Continue Reading
Dr. Aaron Neinstein, Chief Medical Officer at Notable
The health tech industry is undergoing a fundamental transformation as AI-powered automation shifts from a futuristic vision to an immediate necessity. After attending HIMSS 2025 and ViVE 2025, two of…
Continue Reading
